| Announce Date | 01/28/2026 |
| EPS Normalized Actual | $0.58 (Beat by $0.15) |
| EPS GAAP Actual | $0.58 (Beat by $0.15) |
| Revenue Actual | $2.8758B |
| Revenue Surprise | Beat by $2875.8M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.265 |
| EPS GAAP Estimate | $0.265 |
| Revenue Estimate | $2.6564B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2030 | 1.42 | 14.32 | 1.34421 | 1.4728 | 1 |
| Mar 2030 | 1.42 | 14.32 | 1.34621 | 1.47353 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.76 | 0.76 | 2.8758B | 1.46% | 2875.8M |
| FQ3 2025 (Sep 2025) | 0.48 | 0.48 | 2.80271B | 1.6% | 2802.71M |
| FQ2 2025 (Jun 2025) | 0 | 0 | 1.76067B | -8.33% | 1760.67M |
| FQ1 2025 (Mar 2025) | -0.3895 | -0.3895 | 0B | INF% | 0M |
| FQ4 2024 (Dec 2024) | 0.43 | 0.43 | 2.83391B | -4.46% | 2833.91M |
| FQ3 2024 (Sep 2024) | 0.59 | 0.59 | 2.75795B | 24.35% | 2757.95M |
| FQ2 2024 (Jun 2024) | -0.77 | -0.77 | 1.9073B | 100% | 1907.3M |
| FQ1 2024 (Mar 2024) | -0.0056 | -0.0056 | -0.001859B | 100% | -1.86M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
0.265
Consensus Revenue Estimates
2.6564B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 0 | -- | 0 | 0 | 6 |
| FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 10 |
| FQ3 2027 (Sep 2027) | 0.67 | -- | 0.64159 | 0.70815 | 10 |
| FQ2 2027 (Jun 2027) | -0.13 | -- | -0.1374 | -0.12449 | 10 |
| FQ1 2027 (Mar 2027) | 0.045 | -- | 0.04385588 | 0.04749349 | 6 |
| FQ4 2026 (Dec 2026) | 0.57119 | -33.06 | 0.54166 | 0.58966 | 6 |
| FQ3 2026 (Sep 2026) | 0.79333 | 39.5 | 0.77316 | 0.83729 | 6 |
| FQ2 2026 (Jun 2026) | -0.17667 | -- | -0.18646 | -0.17218 | 8 |
| FQ1 2026 (Mar 2026) | 0.265 | 246.98 | 0.25315 | 0.27522 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 2.18B | -- | 2.11B | 2.28B | 4 |
| FQ4 2027 (Dec 2027) | 2.93B | -- | 2.84B | 3.06B | 9 |
| FQ3 2027 (Sep 2027) | 2.85B | -- | 2.76B | 2.97B | 6 |
| FQ2 2027 (Jun 2027) | 1.75B | -- | 1.69B | 1.83B | 5 |
| FQ1 2027 (Mar 2027) | 2.38B | -- | 2.33B | 2.48B | 12 |
| FQ4 2026 (Dec 2026) | 2.87B | -0.19 | 2.76B | 2.94B | 12 |
| FQ3 2026 (Sep 2026) | 2.92B | 3.87 | 2.86B | 3.04B | 11 |
| FQ2 2026 (Jun 2026) | 1.86B | 5.1 | 1.82B | 1.93B | 10 |
| FQ1 2026 (Mar 2026) | 2.66B | -- | 2.57B | 2.74B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 0.76 | 0.76 | 100% | |
| FQ3 2025 (Sep 2025) | 0.48 | 0.48 | 100% | |
| FQ2 2025 (Jun 2025) | 0 | 0 | NAN% | |
| FQ1 2025 (Mar 2025) | -0.3895 | -0.3895 | 100% | |
| FQ4 2024 (Dec 2024) | 0.43 | 0.43 | 100% | |
| FQ3 2024 (Sep 2024) | 0.59 | 0.59 | 100% | |
| FQ2 2024 (Jun 2024) | -0.77 | -0.77 | 100% | |
| FQ1 2024 (Mar 2024) | -0.0056 | -0.0056 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $2.88B | $2875.8M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $2.8B | $2802.71M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.76B | $1760.67M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0B | $0M | NAN% |
| FQ4 2024 (Dec 2024) | $0B | $2.83B | $2833.91M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.76B | $2757.95M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.91B | $1907.3M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $-0B | $-1.86M | 100% |